Viking Therapeutics's market cap is currently $3.26B. The company's EPS TTM is $-1.008; its P/E ratio is ―; Viking Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $-0.33. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -292.00K	$ -291.00K	$ -296.00K	$ -277.00K	$ -260.00K
Operating Income	$ -100.83M	$ -70.36M	$ -55.68M	$ -42.66M	$ -32.69M
EBITDA	$ -100.83M	$ -70.36M	$ -55.39M	$ -42.66M	$ -25.37M
Net Income	$ -85.89M	$ -67.38M	$ -54.00M	$ -36.05M	$ -25.78M
Balance Sheet
Cash & Short-Term Investments	$ 362.08M	$ 155.49M	$ 202.10M	$ 248.39M	$ 275.64M
Total Assets	$ 368.49M	$ 168.53M	$ 210.66M	$ 256.50M	$ 284.26M
Total Debt	$ 1.26M	$ 1.56M	$ 29.00K	$ 359.00K	$ 662.00K
Net Debt	$ -54.26M	$ -35.07M	$ -26.34M	$ -28.76M	$ -7.71M
Total Liabilities	$ 20.07M	$ 23.21M	$ 8.78M	$ 12.16M	$ 7.14M
Stockholders' Equity	$ 348.42M	$ 145.32M	$ 201.88M	$ 244.34M	$ 277.12M
Cash Flow
Free Cash Flow	$ -73.38M	$ -48.40M	$ -47.59M	$ -21.78M	$ -24.75M
Operating Cash Flow	$ -73.38M	$ -48.40M	$ -47.59M	$ -21.78M	$ -24.75M
Investing Cash Flow	$ -179.09M	$ 54.75M	$ 37.96M	$ 41.57M	$ 7.46M
Financing Cash Flow	$ 271.38M	$ 4.16M	$ 6.88M	$ 950.00K	$ 887.00K

Currency in USD

Viking Therapeutics Earnings and Revenue History

Income Statement >

Viking Therapeutics Debt to Assets

Balance Sheet >

Viking Therapeutics Cash Flow

Cash Flow >

Viking Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing